Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Karla Au Yeung

Pediatric Gastroenterology Madera, CA Medical Doctor

NPI 1598794596 CMS profile 835591

9300 Valley Childrens Pl, Madera, CA 93636

Open in the dashboard

General payments

$4,340

154 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$500 paid to institutions, not to them · program year 2023

Through program year 2025, Karla Au Yeung of Madera, CA is reported in the CMS Open Payments database as having received $4,340 across 154 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $500 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 82nd percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,348 45
2024 General $1,099 36
2023 General $853 31
2022 General $659 21
2021 General $201 12
2020 General $121 6
2019 General $61 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Karla Au Yeung
  • Pediatric Gastroenterology median
  • Middle half of Pediatric Gastroenterology
  • National median

In program year 2025, general payments to Karla Au Yeung were reported at $1,348. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.

Show as a table
Year Karla Au Yeung Pediatric Gastroenterology median Middle half National median
2019 $61 $131 $41–$311 $163
2020 $121 $79 $23–$223 $114
2021 $201 $104 $32–$321 $132
2022 $659 $125 $37–$331 $149
2023 $853 $169 $55–$440 $160
2024 $1,099 $196 $73–$563 $164
2025 $1,348 $194 $81–$540 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $2,006 81 payments
  2. Mirum Pharmaceuticals, Inc. $567 12 payments
  3. Genzyme Corporation $327 13 payments
  4. QOL Medical, LLC $232 11 payments
  5. Regeneron Healthcare Solutions, Inc. $185 3 payments
  6. Ipsen Biopharmaceuticals, Inc $176 3 payments
  7. Novo Nordisk Inc $138 2 payments
  8. Pfizer Inc. $115 6 payments
  9. Rhythm Pharmaceuticals, Inc. $105 4 payments
  10. Cook Medical LLC $99 1 payment
  11. Other $391 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,340 154 payments
Products named General payments · program years 2019–2025
  1. RINVOQ $1,203 54 payments
  2. SKYRIZI Immunology $731 29 payments
  3. Livmarli $548 11 payments
  4. SKYRIZI Immunology $547 24 payments
  5. DUPIXENT Immunology $310 12 payments
  6. HUMIRA $285 16 payments
  7. Bylvay $202 5 payments
  8. Wegovy $138 2 payments
  9. DUPIXENT Immunology And Inflammation $125 1 payment
  10. INFLECTRA $115 6 payments
  11. Other $971 40 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

154 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Gastroenterology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record